Skip to content

Northeast Biomedical Labs., Inc.

United StatesFDA applicant, unverified

Devices
9

What Northeast Biomedical Labs., Inc. makes

Northeast Biomedical Labs., Inc. produces biological products for diagnostic and therapeutic use, including guinea pig whole serum and goat-derived antisera targeting rubella and influenza viruses. These antisera are designed for serological testing and immune response assessment in clinical and research settings.

The company’s portfolio includes Class I and Class II devices, with some products authorised via the FDA’s 510(k) pathway. These products are listed under U.S. regulatory frameworks and are manufactured in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue9

Newest first, rows 1-9 of 9

Frequently asked questions

How many devices does Northeast Biomedical Labs., Inc. have in the registry?

The registry currently lists 9 devices for Northeast Biomedical Labs., Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Northeast Biomedical Labs., Inc.'s devices?

Among its 9 most recently registered devices, Northeast Biomedical Labs., Inc. has devices listed in FDA 510(k) (9 devices).

What risk classes do Northeast Biomedical Labs., Inc.'s devices fall under?

Among its 9 most recently registered devices, the classes recorded for Northeast Biomedical Labs., Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

What are the newest devices from Northeast Biomedical Labs., Inc. in the registry?

The most recently registered devices listed for Northeast Biomedical Labs., Inc. include GUINEA PIG WHOLE SERUM, GOAT ANTI-RUBELLA ANTISERA, GOAT ANTI-INFLUENZA ANTISERA and GOAT ANTI-INFLUENZA ANTISERA ATEXAS.

Generated automatically from registry data and not verified by a human reviewer.